Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis

Journal of Experimental Medicine

Volumn 191, Issue 5, 2000, Pages 813-821

  Secor, Virginia H ^a   Secor, W Evan ^b   Gutekunst, Claire Anne ^a   Brown, Melissa A ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

Autoimmunity; Demyelinating diseases; Experimental allergic encephalomyelitis; Inflammation; Myelin associated glycoprotein

Indexed keywords

GLYCOPROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; IMMUNOPATHOGENESIS; INCIDENCE; LYMPHOCYTE ACTIVATION; MAST CELL; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; ONSET AGE; PRIORITY JOURNAL; SYMPTOM; T LYMPHOCYTE SUBPOPULATION;

AGE OF ONSET; AMINO ACID SEQUENCE; ANIMALS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CENTRAL NERVOUS SYSTEM; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; MAST CELLS; MICE; MICE, MUTANT STRAINS; MOLECULAR SEQUENCE DATA; MULTIPLE SCLEROSIS; MYELIN-ASSOCIATED GLYCOPROTEIN; PROTO-ONCOGENE PROTEINS C-KIT;

EID: 0034610971     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.191.5.813     Document Type: Article

References (61)

1. Multiple sclerosis: A coordinated immunological attack against myelin in the central nervous system
2. Pathogenesis of multiple sclerosis
3. Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis
4. An analysis of mast cell frequency in the rodent nervous system: Numbers vary between different strains and can be reconstituted in mast cell-deficient mice
5. Presence and distribution of nervous system-associated mast cells that may modulate experimental autoimmune encephalomyelitis
6. Mast cells in the rat thalamus: Nuclear localization, sex differences, and left-right asymmetry
7. Mast cells in the mammalian central nervous system. Part 1. Morphology, distribution and histochemistry
8. Mast cells as a source of both preformed and immunologically inducible TNF-α/cachectin
9. Differential expression of inflammatory cytokines parallels progression of CNS pathology in two clinically distinct models of MS
10. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions
11. TNF-alpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines
12. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor β, interleukin 4, and prostaglandin E expression in the brain
13. Ueber das Vorkommen der sogneannten 'Mastzellen' bei pathologischen Veraenderungen des Gehirns
14. Identification of IgE-positive cells and mast cells in frozen sections of multiple sclerosis brains
15. Mast cells in plaques of multiple sclerosis
16. Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease
17. Mast cells in experimental allergic encephalomyelitis: Characterization, distribution in the CNS and in vitro activation by myelin basic protein and neuropeptides
18. Elevated mast cell tryptase in cerebrospinal fluid of multiple sclerosis patients
19. An electrophysiological and histological study of trypsin induced demyelination
20. The role of mast cells in demyelination. 1. Myelin proteins are degraded by mast cell proteases and myelin basic protein and P2 can stimulate mast cell degranulation
21. Mast cell proteases liberate stable encephalitogenic fragments from intact myelin
22. The role of mast cells in the elicitation of experimental allergic encephalomyelitis
23. The influence of cinanserin and selected pharmacologic agents on experimental allergic encephalomyelitis (EAE)
24. Modification of the clinical and histopathologic expression of experimental allergic encephalomyelitis by the vasoactive amine antagonist cyproheptadine
25. b mice: Fine specificity and T cell receptor Vβ expression of encephalitogenic T cells
26. Long-term in vitro culture of murine mast cells. II. Purification of a mast cell growth factor and its dissociation from TCGF
27. Critical protective role of mast cells in a model of acute septic peritonitis
28. Analyzing mast cell development and function using mice carrying mutations at W/c-kit or S1/MGF (SCF) loci
29. Development of mucosal mast cells after injection of a single connective tissue-type mast cell in the stomach mucosa of genetically mast cell-deficient W/W(v) mice
30. Demonstration of differential effects of cytokines on mast cells derived from murine bone marrow and peripheral blood mononuclear cells
31. Preferential expression of interleukin-12 or interleukin-4 by murine bone marrow mast cells derived in mast cell growth factor or interleukin-3
32. Myelin oligodendrocyte glycoprotein: A novel candidate autoantigen in multiple sclerosis
33. The M2 autoantigen of central nervous system myelin, a glycoprotein present in oligodendrocyte membrane
34. Identification of autoantibodies associated with myelin damage in multiple sclerosis
35. The mast cells of the multiple sclerosis brain
36. Expression of c-kit gene products in known cellular targets of W mutations in normal and W mutant mice - Evidence for an impaired c-kit kinase in mutant mice
37. 41 and W
38. Decrease of mast cells in W/W(v) mice and their increase by bone marrow transplantation
39. Fate of bone marrow-derived cultured mast cells after intracutaneous, intraperitoneal, and intravenous transfer into genetically mast cell-deficient W/W(v) mice
40. Phenotypic changes of bone marrow-derived mast cells after intraperitoneal transfer into W/W(v) mice that are genetically deficient in mast cells
41. The c-kit ligand, stem cell factor, can enhance innate immunity through effects on mast cells
42. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α
43. Genetically mast-cell-deficient W/W(v) and Sl/Sl(d) mice: Their value for the analysis of the roles of mast cells in biologic responses in vivo
44. Pro-thymocyte expansion by c-kit and the common cytokine receptor gamma chain is essential for repertoire formation
45. Stimulatory effects of hepatocyte growth factor on hemopoiesis of SCF/c-kit system-deficient mice
46. Antibody response in Lewis rats injected with myelin oligodendrocyte glycoprotein derived peptides
47. IgG subclass switching is associated with the severity of experimental autoimmune encephalomyelitis induced with myelin oligodendrocyte glycoprotein peptide in NOD mice
48. Fc receptors
49. Substance P induced histamine release in human cutaneous mast cells
50. Synergistic action of estradiol and myelin basic protein on mast cell secretion and brain myelin changes resembling early stages of demyelination
51. Induction and enhancement of FceRI-dependent mast cell degranulation following coculture with activated T cells: Dependency on ICAM-1-and leukocyte function-associated antigen (LFA)-1-mediated heterotypic aggregation
52. Activated T lymphocytes induce degranulation and cytokine production by human mast cells following cell-to-cell contact
53. Mast cell activation and migration to lymph nodes during induction of an immune response in mice
54. Brain and spinal cord levels of histamine in Lewis rats with acute experimental autoimmune encephalomyelitis
55. Mast cell-derived histamine and tumor necrosis factor: Differences between SJL/J and BALB/c inbred strains of mice
56. A possible role for mast cells in controlling the diameter of arterioles on the surface of the brain
57. Upregulation and coexpression of adhesion molecules correlated with relapsing autoimmune demyelination in the central nervous system
58. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro
59. Local expression of TNF-alpha in neonatal NOD mice promotes diabetes by enhancing presentation of islet antigens
60. Interleukin-10 prevents experimental autoimmune encephalomyelitis in rats
61. In vivo administration of IL-4 induces TGF-β producing cells and protects animals from experimental autoimmune encephalomyelitis